AI Article Synopsis
- The study analyzed F-THK5351 PET scans from patients diagnosed with nonfluent/agrammatic variant primary progressive aphasia (navPPA) to assess brain changes associated with the condition.
- A total of 31 participants were examined, including patients with Alzheimer's disease, navPPA, and normal controls, using advanced imaging techniques and neuropsychological tests.
- Results showed that navPPA patients had increased THK retention in specific brain regions like Broca's area and the frontal lobes, suggesting that tau PET imaging could aid in diagnosing navPPA alongside clinical evaluations.
Article Abstract
Background And Purpose: To analyze F-THK5351 positron emission tomography (PET) scans of patients with clinically diagnosed nonfluent/agrammatic variant primary progressive aphasia (navPPA).
Methods: Thirty-one participants, including those with Alzheimer's disease (AD, =13), navPPA (=3), and those with normal control (NC, =15) who completed 3 Tesla magnetic resonance imaging, F-THK5351 PET scans, and detailed neuropsychological tests, were included. Voxel-based and region of interest (ROI)-based analyses were performed to evaluate retention of F-THK5351 in navPPA patients.
Results: In ROI-based analysis, patients with navPPA had higher levels of THK retention in the Broca's area, bilateral inferior frontal lobes, bilateral precentral gyri, and bilateral basal ganglia. Patients with navPPA showed higher levels of THK retention in bilateral frontal lobes (mainly left side) compared than NC in voxel-wise analysis.
Conclusions: In our study, THK retention in navPPA patients was mainly distributed at the frontal region which was well correlated with functional-radiological distribution of navPPA. Our results suggest that tau PET imaging could be a supportive tool for diagnosis of navPPA in combination with a clinical history.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428011 | PMC |
| http://dx.doi.org/10.12779/dnd.2018.17.3.110 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Heterogeneity of factors associated with cognitive decline and cortical atrophy in early- versus late-onset Alzheimer's disease.
Sci Rep
September 2024
Neuroscience Research Institute, Gachon University, Incheon, Republic of Korea.
The objectives of this study were to investigate the variable factors associated with cognitive function and cortical atrophy and estimated variable importance of those factors in affecting cognitive function and cortical atrophy in patients with EOAD and LOAD. Patients with EOAD (n = 40), LOAD (n = 34), and healthy volunteers with normal cognition were included (n = 65). All of them performed 3T MRI, [F]THK5351 PET (THK), [F]flutemetamol PET (FLUTE), and detailed neuropsychological tests.
View Article and Find Full Text PDFDiverging Relationships among Amyloid, Tau, and Brain Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.
Yonsei Med J
August 2024
Neuroscience Research Institute, Gachon University, Incheon, Korea.
Purpose: Alzheimer's disease (AD) dementia may not be a single disease entity. Early-onset AD (EOAD) and late-onset AD (LOAD) have been united under the same eponym of AD until now, but disentangling the heterogeneity according to the age of sonset has been a major tenet in the field of AD research.
Materials And Methods: Ninety-nine patients with AD (EOAD, n=54; LOAD, n=45) and 66 cognitively normal controls completed both [F]THK5351 and [F]flutemetamol (FLUTE) positron emission tomography scans along with structural magnetic resonance imaging and detailed neuropsychological tests.
Visualizing alpha-synuclein and iron deposition in M83 mouse model of Parkinson's disease in vivo.
Brain Pathol
November 2024
Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland.
Article Synopsis
- Abnormal accumulation of alpha-synuclein (αSyn) and iron in the brain contributes significantly to Parkinson's disease, prompting researchers to visualize these elements in M83 (A53T) mouse models.
- The study utilized THK-565, a fluorescent probe, alongside various imaging techniques like fluorescence and multispectral optoacoustic tomography (vMSOT) to detect αSyn inclusions and iron deposits in vivo and post-mortem.
- Results showed that THK-565 effectively targets αSyn, indicating its higher retention in M83 mice brains compared to nontransgenic controls, and iron accumulation was confirmed through magnetic resonance imaging (SWI) and scanning transmission x-ray microscopy (STXM).
＜Editors' Choice＞ Pattern of THK 5351 retention in normal aging involves core regions of resting state networks associated with higher cognitive function.
Nagoya J Med Sci
November 2023
Brain and Mind Research Center, Nagoya University, Nagoya, Japan.
We aimed to elucidate the distribution pattern of the positron emission tomography probe [18F]THK 5351, a marker for astrogliosis and tau accumulation, in healthy aging. We also assessed the relationship between THK5351 retention and resting state networks. We enrolled 62 healthy participants in this study.
View Article and Find Full Text PDFVisualizing alpha-synuclein and iron deposition in M83 mouse model of Parkinson's disease .
bioRxiv
June 2023
Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland.
Background: Abnormal alpha-synuclein and iron accumulation in the brain play an important role in Parkinson's disease (PD). Herein, we aim at visualizing alpha-synuclein inclusions and iron deposition in the brains of M83 (A53T) mouse models of PD .
Methods: Fluorescently labelled pyrimidoindole-derivative THK-565 was characterized by using recombinant fibrils and brains from 10-11 months old M83 mice, which subsequently underwent concurrent wide-field fluorescence and volumetric multispectral optoacoustic tomography (vMSOT) imaging.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!